Literature DB >> 21541693

Clostridium difficile infection in non-HIV-immunocompromised patients and in HIV-infected patients.

Daniel L Raines1, Fred A Lopez.   

Abstract

Clostridium difficile infection is a common cause of morbidity in patients with HIV infection and in patients with non-HIV immune deficiency. The frequency of C. difficile--associated diarrhea (CDAD) seen in these two patient populations has been attributed to immune deficiency, as well as to increased exposure to hospital environments and antibiotic therapy, both of which are major risk factors for CDAD. This article reviews recent data useful in the evaluation, treatment, and prevention of C. difficile infection in these patient groups. Recent publications relating to C. difficile infection in specific immunocompromised conditions are also discussed.

Entities:  

Mesh:

Year:  2011        PMID: 21541693     DOI: 10.1007/s11894-011-0196-6

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  48 in total

1.  Bacterial diarrhea in HIV-infected patients: why Clostridium difficile, and why now?

Authors:  Sumathi Sivapalasingam; Martin J Blaser
Journal:  Clin Infect Dis       Date:  2005-10-31       Impact factor: 9.079

2.  Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Authors:  Jacques Pépin; Nathalie Saheb; Marie-Andrée Coulombe; Marie-Eve Alary; Marie-Pier Corriveau; Simon Authier; Michel Leblanc; Geneviève Rivard; Mathieu Bettez; Valérie Primeau; Martin Nguyen; Claude-Emilie Jacob; Luc Lanthier
Journal:  Clin Infect Dis       Date:  2005-09-20       Impact factor: 9.079

3.  Clostridium difficile--associated diseases: comparison of symptomatic infection versus carriage on the basis of risk factors, toxin production, and genotyping results.

Authors:  S H Cheng; J J Lu; T G Young; C L Perng; W M Chi
Journal:  Clin Infect Dis       Date:  1997-07       Impact factor: 9.079

4.  Correlation of immunoblot type, enterotoxin production, and cytotoxin production with clinical manifestations of Clostridium difficile infection in a cohort of hospitalized patients.

Authors:  L V McFarland; G W Elmer; W E Stamm; M E Mulligan
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

5.  Evaluation of the C.Diff Quik Chek Complete Assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of clostridium difficile disease.

Authors:  Susan E Sharp; Lila O Ruden; Julie C Pohl; Patricia A Hatcher; Linda M Jayne; W Michael Ivie
Journal:  J Clin Microbiol       Date:  2010-04-07       Impact factor: 5.948

6.  Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates.

Authors:  Thomas Akerlund; Bo Svenungsson; Asa Lagergren; Lars G Burman
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

7.  Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin.

Authors:  T Peláez; L Alcalá; R Alonso; M Rodríguez-Créixems; J M García-Lechuz; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

8.  Chronic kidney disease as a risk factor for Clostridium difficile infection.

Authors:  Rodney Eddi; Mohammed N Malik; Rada Shakov; Walid J Baddoura; Chandra Chandran; Vincent A Debari
Journal:  Nephrology (Carlton)       Date:  2010-06       Impact factor: 2.506

Review 9.  European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI).

Authors:  M J T Crobach; O M Dekkers; M H Wilcox; E J Kuijper
Journal:  Clin Microbiol Infect       Date:  2009-12       Impact factor: 8.067

10.  Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection.

Authors:  C R Clabots; S Johnson; M M Olson; L R Peterson; D N Gerding
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

View more
  4 in total

Review 1.  Clostridium difficile in the ICU: the struggle continues.

Authors:  Linda D Bobo; Erik R Dubberke; Marin Kollef
Journal:  Chest       Date:  2011-12       Impact factor: 9.410

Review 2.  Epidemiology of Clostridium difficile infection.

Authors:  Daryl D Depestel; David M Aronoff
Journal:  J Pharm Pract       Date:  2013-10

3.  Risk factors for Clostridium difficile infection in HIV-infected patients.

Authors:  Hannah Imlay; Daniel Kaul; Krishna Rao
Journal:  SAGE Open Med       Date:  2016-12-14

4.  Enhanced Efficacy of High Dose Oral Vancomycin Therapy in Clostridium difficile Diarrhea for Hospitalized Adults Not Responsive to Conventional Oral Vancomycin Therapy: Antibiotic Stewardship Implications.

Authors:  Burke A Cunha; Julia Sessa; Sharon Blum
Journal:  J Clin Med       Date:  2018-04-10       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.